Randomized, Open‐label Phase 2 Study Comparing Frontline Dovitinib Versus Sorafenib in Patients with Advanced Hepatocellular CarcinomaAnn-Lii Cheng,Sumitra Thongprasert,Ho Yeong Lim,Wattana Sukeepaisarnjaroen,Tsai-Shen Yang,Cheng-Chung Wu,Yee Chao,Stephen L. Chan,Masatoshi Kudo,Masafumi Ikeda,Yoon-Koo Kang,Hongming Pan,Kazushi Numata,Guohong Han,Binaifer Balsara,Yong Zhang, Ana-Marie Rodriguez, Yi Zhang,Yongyu Wang,Ronnie T. P. PoonHepatology(2016)引用 101|浏览59关键词SorafenibAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要